LUCY
Innovative Eyewear, Inc.
There isn't enough reported data to score LUCY yet.
LUCY Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
LUCY's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LUCY PE Valuation
LUCY has no meaningful PE right now: it lost money over the past year.
LUCY Forward outlook
There aren't enough analyst estimates for LUCY to show an outlook.
LUCY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.04 | +$2.90 |
| Q2 2026 | -$1.15 | +$3.40 |
| Q1 2026 | -$1.55 | +$4.21 |
| Q4 2025 | -$1.90 | +$6.14 |
| Q3 2025 | -$3.94 | +$5.72 |
| Q2 2025 | -$4.55 | +$6.52 |
| Q1 2025 | -$5.76 | +$6.44 |
| Q4 2024 | -$8.04 | +$4.56 |
LUCY is still losing money, but far less than before: $1.04 per share over the past year, against $15.84 at its worst in mid-2022.
LUCY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1M | +51% |
| Q2 2026 | $1M | +74% |
| Q1 2026 | $773.6K | +70% |
| Q4 2025 | $959.8K | +39% |
| Q3 2025 | $668.1K | +163% |
| Q2 2025 | $579.2K | +88% |
| Q1 2025 | $454.5K | +19% |
| Q4 2024 | $690.7K | +12% |
LUCY's revenue has grown year over year for 13 quarters in a row: $1M last quarter, up 51% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2022 | -503% | -319 points |
| Q4 2021 | -501% | +393 points |
| Q3 2021 | -638% | +452 points |
| Q2 2021 | -408% | +1115 points |
| Q1 2021 | -185% | +1338 points |
| Q4 2020 | -894% | N/A |
| Q3 2020 | -1090% | N/A |
| Q2 2020 | -1523% | N/A |
LUCY's operating margin was −503% last quarter, down 319 points from the same quarter a year ago.
LUCY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.4M | +$602.4K |
| Q3 2025 | -$1.5M | -$112.6K |
| Q2 2025 | -$2.1M | -$183.7K |
| Q1 2025 | -$2.4M | -$852K |
| Q4 2024 | -$2M | -$860K |
| Q3 2024 | -$1.4M | +$30K |
| Q2 2024 | -$1.9M | -$82.6K |
| Q1 2024 | -$1.5M | -$44.4K |
LUCY has burned cash in almost every quarter: −$7M over the past year, against −$7M the year before.
LUCY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +31% | +2M shares |
| 1 year | +162% | +5.2M shares |
| 3 years | +1900% | +8M shares |
| 5 years | +3769% | +8.2M shares |
| Available history | +8365% | +8.3M shares |
LUCY has 8M diluted shares, up 162% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
LUCY Net Leverage
LUCY's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LUCY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.2 | Neutral |
| Stochastic | 24.7 | Neutral |
LUCY's weekly RSI is 44 (neutral) and its Stochastic is 25 (neutral).
LUCY PE vs Healthcare Sector
LUCY has no meaningful PE right now: it lost money over the past year.
LUCY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.86 | 5.8% below |
| 20 week MA | $0.83 | 2.4% below |
| 50 week MA | $1.01 | 20% below |
| 100 week MA | $1.96 | 59% below |
| 200 week MA | $8.99 | 91% below |
LUCY is in a downtrend: it's below all five of its weekly moving averages, and 91% below its 200-week average.
LUCY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $96.0 | $15.5 | -84% |
| 2023 | $15.5 | $8.44 | -46% |
| 2024 | $8.44 | $5.02 | -41% |
| 2025 | $5.02 | $1.22 | -76% |
| 2026 YTD | $1.22 | $0.81 | -34% |
LUCY has finished every year since 2022 lower, and it's down 34% so far in 2026.